Drug Type Gene therapy |
Synonyms AD5-E10A, E 10A, E-10-A + [5] |
Target |
Mechanism VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nasopharyngeal Carcinoma | Phase 3 | CN | 08 Jul 2013 | |
Squamous Cell Carcinoma of Head and Neck | Phase 3 | CN | 08 Jul 2013 |
Phase 1 | 34 | ouppdssxcm(cjmgtffkti) = wfszmxkcoa abyklcqnwb (rtiieetpni, 23.7 - 58.6) View more | Positive | 01 Feb 2022 | |||
Phase 2 | 53 | hcrpayigde(emwhtszaeb) = zsvucbaqrd sskeunmadc (rdbfqhzhjd, 3.7 - 6.6) View more | Positive | 01 Apr 2021 | |||
Phase 2 | 50 | chemoradiotherapy+Endostar | ilfhxdwucx(tloanncfjk) = wdmtdfmiug lbquvrgfar (uhvpwtdfpe ) View more | Positive | 01 Feb 2015 | ||
Phase 2 | 140 | uojyuebbbo(ispnicznxe) = xtqsygyviy budmrhyvzs (aypojcrgjg ) View more | Positive | 29 Jul 2014 | |||
Chemotherapy | uojyuebbbo(ispnicznxe) = xqnlceskae budmrhyvzs (aypojcrgjg ) View more |